首页> 外文期刊>International journal of oncology >Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP
【24h】

Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP

机译:食管鳞癌细胞EC109及其多药耐药亚细胞EC109 / CDDP的比较蛋白质组学分析

获取原文
           

摘要

To gain insights into the mechanisms of drug resistance in esophageal squamous cell carcinoma (ESCC), we employed proteomic techniques to study the global protein change of the multi-drug resistant ESCC cell line EC109/CDDP, which was established in our previous work, in comparison with its parental drug sensitive cell line EC109. By two-dimensional electrophoresis and mass spectrometry, we successfully identified 44 proteins with altered expression levels. These proteins are involved in endoplasmic reticulum stress response, metabolic process, DNA replication and repair, nucleotide binding, calcium binding, and cytoskeletal proteins. Among them, the differential expression levels of thioredoxin domain-containing protein 4 precursor and cystathionine γ-lyase were further validated by Western blot and RT-PCR. Our present results lay foundation for future in-depth work on molecular mechanism of ESCC drug resistance, and aid in the identification and use of novel markers in clinical practice.
机译:为了深入了解食管鳞状细胞癌(ESCC)耐药机制,我们采用蛋白质组学技术研究了多药耐药ESCC细胞系EC109 / CDDP的整体蛋白变化,该蛋白是我们先前的工作建立的。与其亲代药物敏感性细胞系EC109进行比较。通过二维电泳和质谱,我们成功地鉴定了44种表达水平发生改变的蛋白质。这些蛋白参与内质网应激反应,代谢过程,DNA复制和修复,核苷酸结合,钙结合和细胞骨架蛋白。其中,通过Western blot和RT-PCR进一步验证了含有硫氧还蛋白结构域的蛋白4前体和胱硫醚γ-裂解酶的差异表达水平。我们目前的结果为将来在ESCC耐药性分子机制上的深入研究奠定了基础,并有助于在临床实践中鉴定和使用新型标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号